Skip to content

Observation of the clinical efficacy of Jia wei ding chan Decoction in the treatment of patients with tremor disease (Parkinson's disease) with deficiency of qi and blood and deficiency wind internal movement syndrome

Observation of the clinical efficacy of Jia wei ding chan Decoction in the treatment of patients with tremor disease (Parkinson's disease) with deficiency of qi and blood and deficiency wind internal movement syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000967
Enrollment
Unknown
Registered
2026-04-16
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

the treatment group:Jiawei Ding Chan Decoction on the basis of conventional Western medicine

Sponsors

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 90 Years

Inclusion criteria

Inclusion criteria: People aged 35-90 years old, diagnosed by Western medicine as primary Parkinsonism. Traditional Chinese medicine diagnosed tremor syndrome with tremor as the main symptom, and the syndrome is patients with deficiency of qi and blood, deficiency of wind and internal movement of Parkinson's disease. Those who have been ill for more than 3 months.Voluntarily participate in this study, sign the informed consent form, and be able to cooperate with the completion of the entire treatment and follow-up.

Exclusion criteria

Exclusion criteria: All kinds of Parkinson's syndrome and Parkinson's syndrome; suffering from severe liver, kidney, heart, endocrine, metabolic disorders, hematopoietic system diseases, malignant tumors, mental disorders, epilepsy, blindness, aphasia; unable to tolerate, unable to accept or complete treatment as required.Those who are allergic to the Western medicine or the drugs used in this study;Those who have participated in other clinical trials in the past 3 months; Those with poor compliance and are expected to be unable to complete the full course of treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale;Traditional Chinese medicine syndrome scale scoring;

Secondary

MeasureTime frame
Pittsburgh sleep quality index;Montreal cognitive Assessment;Beck anxiety inventory;Beck depression inventory;Blood vitamin D level;Serum uric acid level;

Countries

china

Contacts

Public Contactwangyan

BoZhou Hospital of Traditional Chinese Medicine

bzzyywy@163.com15955670901

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026